Keyphrases
Lipopolysaccharide
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Interleukin-10 Knockout Mouse
100%
Endotoxin Priming
100%
Wild Mice
42%
Interleukin-10
42%
Interleukin-12 (IL-12)
42%
IL-10 Knockout Mice
42%
Spleen
28%
Interferon-α (IFN-α)
28%
Lipopolysaccharide Tolerance
28%
Systemic Clearance
28%
Lung
14%
Systemic Infection
14%
Anti-inflammatory Cytokines
14%
Cytokine Production
14%
Immunosuppression
14%
Lipopolysaccharide Endotoxin
14%
Lipopolysaccharide-induced
14%
Endotoxin
14%
Interferon-γ
14%
Systemic Challenges
14%
Prior Exposure
14%
Opportunistic Pathogens
14%
IL-10 Production
14%
Lipopolysaccharide Challenge
14%
Altered States
14%
Post-inflammatory
14%
Immunology and Microbiology
Knockout Mouse
100%
Wild Type
100%
Interleukin 10
100%
Pseudomonas aeruginosa
100%
Mouse
66%
Wild Type Mouse
50%
Interleukin 12
50%
interferon
33%
Cytokine
16%
Infectious Agent
16%
Secretion (Process)
16%
Inflammatory Cytokine
16%
Cytokine Production
16%
Neutralization
16%
Immunosuppression
16%
Interferon Gamma
16%
Pharmacology, Toxicology and Pharmaceutical Science
Knockout Mouse
100%
Lipopolysaccharide
100%
Pseudomonas aeruginosa
100%
Endotoxin
100%
Interleukin 10
100%
Mouse
36%
Wild Type Mouse
27%
Cytokine
27%
Interleukin 12
27%
Interferon
18%
Infectious Agent
9%
Sepsis
9%
Anti-Inflammatory Drug
9%
Gamma Interferon
9%